Senior insider sale
CHIEF FINANCIAL OFFICER at MIRUM PHARMACEUTICALS, INC. — senior position signals high conviction
$2.19M
20.94K shares
What this filing means
BJERKHOLT ERIC plans to sell 20.94K shares of MIRUM PHARMACEUTICALS, INC. valued at approximately $2.19M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001197350-26-000011
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
20.94K
Shares to sell
$2.19M
Approx. market value
9.94K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation for services rendered to Issuer
9/11/2026
9.94KTotal acquired9.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/11/2026 | Restricted Stock Units vesting under registered plan Compensation for services rendered to Issuer | 9.94K | — |
| Total | 9.94K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6K
Market value
$599.5K
8/11/2026
—Completed
Units to sell
5K
Market value
$611.3K
7/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.94K
Market value
$978.1K
9/14/2026
Total
Units
20.94K
Value
$2.19M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/11/2026 | 6K | $599.5K | — | Completed |
7/6/2026 | 5K | $611.3K | — | Completed |
| Planned — Approximate Date | ||||
9/14/2026 | 9.94K | $978.1K | NASDAQ | Planned |
| Total | 20.94K | $2.19M | ||